The , has delivered a decisive verdict in favor of the Swiss pharmaceutical giant , ruling that proceeds from the assignment of its Indian trademarks are not taxable as under Indian law or the . The bench, comprising Judicial Member Smt. Beena Pillai and Accountant Member Shri Arun Khodpia, concluded that the transaction represented an of rather than a mere license to use intellectual property, thereby granting the company significant relief from a tax demand exceeding ₹433 crore.
The controversy originated from the assessment year , during which Novartis transferred several of its registered pharmaceutical trademarks—specifically the JALRA/JALRA-M, VYSOV/VYSOV-M, and ZOMELIS/ZOMELIS-M marks—to domestic pharmaceutical entities, namely , , and Novartis declared the substantial consideration received from these assignments as , asserting they were not taxable in India under . However, the and the contended that the nature of these transfers was restricted, arguing that the inclusion of and meant the Indian purchasers were essentially paying for the right to use the trademarks, characterizing the receipt as "royalty" under .
In its comprehensive order, the Tribunal meticulously parsed the terms of the . The bench found that the agreements expressly transferred ownership of the Indian trademark rights, along with the associated , to the respective purchasers. The Tribunal rejected the Revenue’s reliance on the existence of post-assignment restrictions, clarifying that these were standard protective measures rather than indicia of retained ownership.
Highlighting the nature of the transaction, the Tribunal stated,
"The description of a mark as a word mark concerns the form of the registered mark; it does not reduce proprietorship to a licence or permission to use it."
The bench further clarified that the legal transfer of a registered property, such as a trademark, does not compel the seller to part with every vestige of its corporate identity. The order observed,
"Sale of that registered property does not require sale of the assignor's entire corporate identity, house marks or every element of packaging."
Distinguishing from Usage Rights
A critical component of the Tribunal’s reasoning was the distinction between the
"use of or right to use"
intellectual property—which triggers the royalty definition—and the "
" of property. By reviewing the specific clauses of the deed with
, the ITAT observed that Novartis had divested itself of all interest in the trademarks within the Indian territory, rendering it incapable of claiming further ownership rights in those specific marks locally. The territorial limitation was not a retention of the transferred rights, but rather a definition of the property that had been alienated.
Furthermore, the Tribunal dismissed the argument that the absence of a recorded acquisition cost for self-generated trademarks implied the non-existence of a capital asset. It noted that the presence of the trademarks in the official , where the purchasers were now recorded as proprietors, served as definitive proof of the change in ownership. The court found that the fixed, lump-sum nature of the consideration—which was not contingent upon future sales, profits, or productivity of the products—further undermined the Revenue's attempt to categorize the payments as royalty.
Regulatory and Contractual Implications
The Revenue’s case had relied heavily on the fact that the purchasers were prohibited from exporting products bearing the marks and had to maintain certain product standards. However, the ITAT emphasized that such contractual obligations, including regulatory responsibilities, product presentation standards, and trade dress requirements, were distinct from the ownership of the trademark itself. The Tribunal determined that these covenants were intended to preserve the reputation of the global brand, not to retain ownership of the Indian assets, which had already been assigned to the new proprietors.
The Tribunal also pointed out that allocates the taxation of gains from the of intangible property to the Contracting State of residence, which in this instance is Switzerland. Since the Revenue failed to prove that the trademarks formed part of a of the in India, the application of Article 13(6) was deemed appropriate. By establishing that the transaction was a legitimate transfer of assets, the ITAT successfully blocked the Revenue from applying the domestic definition of royalty under Section 9(1)(vi) of the Income-tax Act.
Conclusion and Practical Consequences
With this ruling, the Tribunal deleted the entire addition of ₹433,14,76,894, effectively setting aside the tax demand that had been upheld by the DRP. Given that the main contention regarding the characterization of the receipts was decided in favor of the under the treaty, the Tribunal found it unnecessary to adjudicate the alternative arguments concerning domestic tax laws or the applicability of surcharge and cess, deeming them academic.
The decision serves as a significant precedent for multinational entities involved in the restructuring of intellectual property within the Indian market. It reaffirms that in the context of international tax treaties, the substance of an assignment—characterized by the irrevocable transfer of rights and titles—takes precedence over restrictive protective clauses that do not fundamentally alter the nature of the ownership shift. The appeal was allowed as a partial success, with the core relief granted through the deletion of the disputed tax addition. Following this judgment, the legal challenges related to the DRP’s directions and the limitations on the assessment order were dismissed as infructuous, as the substantive victory rendered those grounds secondary. The assessment for the relevant year is thus adjusted to reflect the non-taxable status of these receipts in India, barring any further appeal from the Revenue side.
trademark assignment taxation - international treaty benefits